Orajel Extra Strength (Benzocaine)

Orajel Extra Strength contains benzocaine, a topical anesthetic that acts on oral soft tissues to reduce pain.

• Toothache: temporary relief of dental pain caused by caries or trauma.
• Oral mucosal pain: eases discomfort from mouth sores, ulcerations or irritation.
• Dental procedures: numbs the area during minor dental work or examinations.

• Benzocaine exerts its effect by reversibly inhibiting voltage‑gated sodium channels on peripheral nerve membranes. This blockade prevents the initiation and propagation of nerve impulses, thereby reducing the transmission of pain signals from the site of application to the central nervous system.

Adverse reactions are generally localized and may vary in frequency.

Common Side Effects

• Mild burning or stinging at the application site.
• Temporary numbness of the surrounding oral tissues.
• Slight redness or irritation of the mucosa.
• Minor swelling or edema where applied.
• Taste alteration lasting a short period.
• Dry mouth sensation.

Serious or Rare Side Effects

• Allergic reaction presenting as rash, itching or swelling.
• Methemoglobinemia, a rare blood disorder causing cyanosis.
• Severe mucosal ulceration or necrosis.
• Persistent numbness extending beyond the intended area.
• Systemic toxicity if excessive amounts are absorbed.
• Anaphylactic shock requiring immediate medical attention.

When using Orajel Extra Strength, consider the following safety measures.

• Age restriction: avoid use in children under two years unless directed by a healthcare professional.
• Application limit: use only the recommended amount and avoid prolonged contact.
• Pre‑existing conditions: exercise caution in patients with known hypersensitivity to benzocaine or other local anesthetics.
• Concomitant use: do not combine with other topical anesthetics on the same site without medical advice.
• Monitoring: discontinue use if signs of methemoglobinemia or severe irritation appear.
• Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture and direct sunlight.

Benzocaine may interact with certain substances, altering its safety profile.

Major Interactions (Avoid)

• Other topical anesthetics containing benzocaine or similar agents: risk of cumulative toxicity.
• Systemic oxidizing agents (e.g., nitrites, certain antibiotics): may increase methemoglobinemia risk.

Moderate Interactions (Monitor Closely)

• Phenylephrine‑containing decongestants: may enhance vasoconstrictive effects.
• High‑dose vitamin C supplements: potential alteration of oxidative balance.
• Alcohol‑based mouth rinses: may increase mucosal irritation when used together.